These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 8301149)

  • 1. Up-regulation of the MHC class II molecules on B cells by peptide ligands.
    Agrawal B; Fraga E; Kane K; Singh B
    J Immunol; 1994 Feb; 152(3):965-75. PubMed ID: 8301149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral peptide specific induction of MHC class II expression by murine T cell clones.
    Thomas DB; Smith CA; Graham CM
    J Immunol; 1996 Sep; 157(6):2386-94. PubMed ID: 8805637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of antigen presentation and class II expression by a class II-associated invariant chain peptide.
    Zechel MA; Chaturvedi P; Lee-Chan EC; Rider BJ; Singh B
    J Immunol; 1996 Jun; 156(11):4232-9. PubMed ID: 8666792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II-restricted presentation of native protein antigen by B cells is inhibitable by cycloheximide and brefeldin A.
    St-Pierre Y; Watts TH
    J Immunol; 1990 Aug; 145(3):812-8. PubMed ID: 2373860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells that recognize peptide sequences of self MHC class II molecules exist in syngeneic mice.
    Agrawal B; Manickasundari M; Fraga E; Singh B
    J Immunol; 1991 Jul; 147(2):383-90. PubMed ID: 1649218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the signaling function of MHC class II molecules during antigen presentation by B cells.
    St Pierre Y; Watts TH
    J Immunol; 1991 Nov; 147(9):2875-82. PubMed ID: 1680921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mutant antigen-presenting cell defective in antigen presentation expresses class II MHC molecules with an altered conformation.
    Dang LH; Lien LL; Benacerraf B; Rock KL
    J Immunol; 1993 May; 150(10):4206-17. PubMed ID: 8482833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inefficient peptide binding by cell-surface class II MHC molecules.
    Sherman MA; Weber DA; Spotts EA; Moore JC; Jensen PE
    Cell Immunol; 1997 Nov; 182(1):1-11. PubMed ID: 9427804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A defect in the presentation of intracellular viral antigens is restored by interferon-gamma in cell lines with impaired major histocompatibility complex class I assembly.
    Sibille C; Gould K; Hämmerling G; Townsend A
    Eur J Immunol; 1992 Feb; 22(2):433-40. PubMed ID: 1537379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Processing of an endogenous protein can generate MHC class II-restricted T cell determinants distinct from those derived from exogenous antigen.
    Moreno J; Vignali DA; Nadimi F; Fuchs S; Adorini L; Hämmerling GJ
    J Immunol; 1991 Nov; 147(10):3306-13. PubMed ID: 1658143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.
    Jefferies WA; Kolaitis G; Gabathuler R
    J Immunol; 1993 Sep; 151(6):2974-85. PubMed ID: 8397249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
    Hitzel C; van Endert P; Koch N
    J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. I-Ak polymorphisms define a functionally dominant region for the presentation of hen egg lysozyme peptides.
    Rosloniec EF; Vitez LJ; Beck BN; Buerstedde JM; McKean DJ; Landais D; Benoist C; Mathis D; Freed JH
    J Immunol; 1989 Jul; 143(1):50-8. PubMed ID: 2786533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 envelope protein is expressed on the surface of infected cells before its processing and presentation to class II-restricted T lymphocytes.
    Callahan KM; Rowell JF; Soloski MJ; Machamer CE; Siliciano RF
    J Immunol; 1993 Sep; 151(6):2928-42. PubMed ID: 8376762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invariant chain influences the immunological recognition of MHC class II molecules.
    Peterson M; Miller J
    Nature; 1990 May; 345(6271):172-4. PubMed ID: 1692393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invariant chain association with MHC class I: preference for HLA class I/beta 2-microglobulin heterodimers, specificity, and influence of the MHC peptide-binding groove.
    Vigna JL; Smith KD; Lutz CT
    J Immunol; 1996 Nov; 157(10):4503-10. PubMed ID: 8906828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens.
    Bikoff EK
    J Immunol; 1992 Jul; 149(1):1-8. PubMed ID: 1318896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.